Status
Conditions
Treatments
About
The objective of this retrospective study is an investigational clinical follow-up, of patients treated with interbody fusion devices (IBFD), both expandable (EXP) and static (STC), according to their intended use and cleared labeling to understand IBFD design and technique characteristics that affect occurrence rates of subsidence.
Patients treated with IBFD's (both EXP and STC) according to their intended use and cleared labeling
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
The patient was treated with TLIF or PLIF surgery using the IBFD according to the cleared labeling, based on the surgeon's clinical judgment and patient-specific decision making. Based on the product labeling, the patient must:
Was at least 18 years of age and skeletally mature at the time of surgery
Had clinical and radiological evidence of DDD of the lumbar spine
Undergone treatment with the IBFD with autogenous bone graft and/or allogeneic bone graft composed of cancellous and/or corticocancellous bone at 1 or 2 contiguous levels from L2 to S1
Exclusion criteria
Loading...
Central trial contact
Brooke O'Connell, MS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal